Counterfeit Drug Network Busted
On September 1, 2025, a major counterfeit drug network was dismantled by Delhi Police, leading to the arrest of several individuals, including Tanishq Jha, whose factory in Patna was found to be producing counterfeit medicines after its license had expired.
The police operation began with a trap set to catch a courier delivering Tramadol premix. Anirudh Rai was apprehended while delivering a package containing this controlled substance. The investigation revealed a complex network linking suppliers in Uttarakhand to traders in Delhi and a manufacturer in Bihar.
Authorities seized counterfeit medicines and psychotropic drugs valued at nearly Rs 50 crore during the operation. Amit, another suspect, was found to have stored 20 kilograms of Tramadol premix in his warehouse in Roorkee, while Prashant acted as an intermediary connecting suppliers to buyers across North India.
According to a senior Crime Branch officer, “The goal was to trace the supply chain behind the material.” This operation highlighted the intricate web of suppliers, brokers, transporters, and manufacturing units involved in the counterfeit drug trade.
Crime Branch officers noted that when factories shut down or excess stock remains in warehouses, middlemen often attempt to move the material quickly. The profits from these operations are typically shared between the middlemen and the traders who source the material.
The pharmaceutical belt around Roorkee has seen many small manufacturers emerge since Uttarakhand was carved out of Uttar Pradesh, contributing to the ongoing challenges in regulating the drug supply chain.
As investigations continue, officials are examining the broader implications of this counterfeit network on public health and safety. The operation has drawn attention to the need for stricter regulations and oversight in the pharmaceutical industry.
Details remain unconfirmed regarding the full extent of the network and the number of individuals involved. However, the arrests made so far indicate a significant crackdown on illegal drug manufacturing and distribution.
Authorities are expected to provide further updates as the investigation unfolds, aiming to dismantle any remaining links in this extensive counterfeit operation.
